Table 4 PCSK9 levels in relation to MACEs in patients with different diabetic status

Non-DM

 PCSK9 per-SD increase

1.543 (1.224–1.945)^b

1.571 (1.232–2.004)^b

1.458 (1.128–1.885)^b

 PCSK9 < 234.52 ng/mL

1.0 (Reference)

1.0 (Reference)

1.0 (Reference)

 PCSK9 ≥ 234.52 ng/mL

2.137 (1.210–3.775)^b

2.140 (1.206–3.795)^b

2.100 (1.174–3.757)^a

DM

 PCSK9 per-SD increase

1.258 (0.975–1.623)

1.262 (0.972–1.639)

1.361 (1.037–1.785)^a

 PCSK9 < 234.52 ng/mL

2.430 (1.264–4.467)^b

2.424 (1.260–4.663)^b

3.033 (1.442–6.376)^b

 PCSK9 ≥ 234.52 ng/mL

4.092 (2.297–7.290)^b

4.084 (2.274–7.333)^b

5.233 (2.546–10.757)^b